{
    "clinical_study": {
        "@rank": "5042", 
        "acronym": "80+", 
        "arm_group": [
            {
                "arm_group_label": "Conservative therapy", 
                "arm_group_type": "No Intervention", 
                "description": "Optimized medical therapy"
            }, 
            {
                "arm_group_label": "Invasive therapy", 
                "arm_group_type": "Experimental", 
                "description": "Coronary angiography and revascularization if feasible"
            }
        ], 
        "brief_summary": {
            "textblock": "A multicenter, randomized clinical trial in elderly patients (over 80 years old) with\n      unstable angina pectoris or Non-ST elevation myocardial infarction (NSTEMI).\n\n      A total of 200 patients will be randomized to medical treatment (100 patients) or coronary\n      angiography with revascularization if feasible (100 patients). Information regarding prior\n      history, frailty, clinical presentation, in-hospital events, complications, angina, quality\n      of life and mortality will be collected. Follow up time is 1 year."
        }, 
        "brief_title": "Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Non-ST Elevation Myocardial Infarction (NSTEMI)", 
            "Angina, Unstable"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Angina, Unstable", 
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. >80 years of age\n\n          2. Acute coronary syndrome with ischemic symptoms (mainly chest pain) lasting over 10\n             minutes during the last 72 hours.\n\n             AND at least one of the following:\n\n               1. ST-segment depression on ECG  > 1mm\n\n               2. Elevated cardiac troponins\n\n          3. Written informed consent before randomization\n\n        Exclusion criteria:\n\n          1. Percutaneous coronary intervention (PCI) within 30 days prior to randomization\n\n          2. Suspected ongoing active internal bleeding\n\n          3. ST segment elevation of >1mm in two contiguous leads on ECG\n\n          4. Enrollment in another study that has not completed the follow up phase.\n\n          5. Known allergy to aspirin or clopidogrel\n\n          6. Severe dementia\n\n          7. Expected limited 1 year survival due to other disease(s)\n\n          8. Unwillingness to participate in the trial or expected problems with compliance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "80 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 7, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02126202", 
            "org_study_id": "80+"
        }, 
        "intervention": {
            "arm_group_label": "Invasive therapy", 
            "description": "Coronary angiography and revascularization with PCI or CABG (coronary artery bypass grafting) if feasible", 
            "intervention_name": "Coronary angiography and revascularization if feasible", 
            "intervention_type": "Procedure", 
            "other_name": "Percutaneous coronary intervention (PCI)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Elderly", 
            "Octogenarians", 
            "PCI", 
            "Myocardial infarction", 
            "NSTEMI", 
            "Unstable angina pectoris"
        ], 
        "lastchanged_date": "April 27, 2014", 
        "location": {
            "contact": {
                "email": "berglind.libungan@vgregion.se", 
                "last_name": "Berglind Libungan, MD", 
                "phone": "+46313421000"
            }, 
            "facility": {
                "address": {
                    "city": "Gothenburg", 
                    "country": "Sweden", 
                    "zip": "41345"
                }, 
                "name": "Department of Cardiology, Sahlgrenska University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes: The Octogenarians Study", 
        "overall_contact": {
            "email": "per.albertsson@vgregion.se", 
            "last_name": "Per A Albertsson, MD, PhD", 
            "phone": "+46313421000"
        }, 
        "overall_official": {
            "affiliation": "Sahlgrenska University Hospital, Sweden", 
            "last_name": "Per A Albertsson, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of participants with major adverse cardiac and cerebral events (the composite of death, myocardial infarction, urgent revascularisation, recurrent hospitalization due to cardiac reason and stroke).", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02126202"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sahlgrenska University Hospital, Sweden", 
            "investigator_full_name": "Per Albertsson", 
            "investigator_title": "Head of Cardiology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of participants with major bleeding", 
                "safety_issue": "Yes", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Number of participants with major adverse cardiac or cerebral event", 
                "safety_issue": "No", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Number of participants with minor bleeding", 
                "safety_issue": "Yes", 
                "time_frame": "1 month"
            }, 
            {
                "measure": "Number of participants with composite of cardiac death or myocardial infarction", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Change from baseline of participants level of quality of life measured with the SF-36 questionnaire at 12 months", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "Change from baseline of participants level of angina pectoris at 12 months", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "measure": "Number of participants dead (all cause mortality)", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Sahlgrenska University Hospital, Sweden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sahlgrenska University Hospital, Sweden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2009", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}